Proteome Sciences (PRM)


PRM Share PerformanceMore

52 week high23.940 21/04/16
52 week low9.000 21/09/16
52 week change -4.500 (-28.80%)
4 week volume7,126,761 04/09/16

Media for (PRM)

Presenter: Christopher Pearce

Latest NewsMore

Holding(s) in Company

RNS Number: 1393L Proteome Sciences PLC 29 September 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii PROTEOME SCIENCES 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights...

FTSE rallies on strong miners

The blue chip index's rally continued as higher commodity prices attracted investors to resources stocks. The FTSE 100 close...

Publication: Journal of Alzheimer's disease

RNS Number: 5050K Proteome Sciences PLC 22 September 2016 PRESS RELEASE Proteome Sciences plc Study Demonstrates Mass Spectrometry Technique Dramatically Enhances Detection of Key Early Stage Alzheimer's Biomarkers. Publication: Journal of Alzheimer's disease For immediate release: 22nd September 2016, Cobham, UK: A peer reviewed study led b...

Proteome Sciences revenues up

Proteome Sciences said revenues to 30 June increased 32% to 1.12 million (2015: 0.85 million). Licences/sales/services revenues...

Half-year Report

RNS Number: 8681J Proteome Sciences PLC 15 September 2016 15 th September 2016 Proteome Sciences plc ("Proteome Sciences" or the "Company") INTERIM RESULTS Proteome Sciences today releases its unaudited interim results for the six months ended 30 th June 2016. Financial highlights: Revenues to 30 th June increased 32% to 1.12m (2015: 0.85m) Licences/sales/...

Proteome Sciences revenue up

Proteome Sciences said revenues in the first half were significantly ahead of the equivalent period in 2015 driven principal...

Trading Update and Notice of Results

RNS Number: 4575F Proteome Sciences PLC 28 July 2016 Proteome Sciences plc (the "Company" or the "Group") Trading Update and Notice of Results The Company is pleased to provide a trading update for the six months ending 30 th June 2016. Revenues in the first half are significantly ahead of the equivalent period in 2015 driven principally by strong sales of ou...

Proteome Sciences on track

Proteome Sciences is on track to deliver a significant increase in revenues, shareholders at the annual general meeting were...

Fundamental DataMore

Dividend yield0 %

Equity Research (PRM)

edison investment research
Proteome Sciences plc
Edison Investment Research is terminating coverage on Proteome Sciences (PRM). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now...
edison investment research
Proteome Sciences plc
Proteome Sciences signed its first major biomarker service contract in September. This followed on from the data from the 1,148-patient Alzheimer’s disease (AD) study, which could lead to a blood-...

Latest discussion posts More

  • Re: Wow, the Guru is bullish

    No irony intended. Sarcasm maybe. Regarding info on holdings, I asked you for the same some time ago! TP
    The Potter
  • Re: Wow, the Guru is bullish

    WP/TP - its fascinating you are so fixated with my view of PRM, but so rarely discuss PRM. How many PRM shares do you hold, at what average price, and for how long? Now ...
    Andy Reilly
  • Re: Wow, the Guru is bullish

    If it's a move up in the SP, it's ALWAYS "market sentiment"! :)
    Waiting patiently

Users' HoldingsMore

Users who hold Proteome Sciences also hold..

Codes & Symbols